Investor News


October 13, 2017
Milestone on Bayer's path to completing the planned acquisition of Monsanto:

Bayer signs agreement to sell selected Crop Science businesses to BASF for EUR 5.9 billion

more


News Overview

 

New Investors

Your are interested in Bayer as a new investor? On this page you find helpful links to information on the company and our shares, latest financial reports and key figures, news and events, corporate governance, sustainability and services for investors.

New Investors

Institutional Investors and Analysts

You are an institutional investor or financial analyst and cover Bayer? Find here a collection of helpful links to information on the company and our shares, latest financial reports, consensus estimates, news, events and services.

Institutional Investors and Financial Analysts

Private Investors

You are a private shareholder and interested in an investment in Bayer shares? Here you find our information offer tailored to private investors, including information on the company and our shares, latest financial reports and key figures, news and events, corporate governance and shareholder services.

Private Investors

Socially Responsible Investing

Sustainable business practices are essential to our company’s future viability. We apply our scientific expertise and innovation strength to help solve global challenges. Our goal in developing, manufacturing and marketing our products is to balance commercial success with societal and ecological requirements while increasing enterprise value.

Socially Responsible Investing

Bond Investors

You are interested in an investment in Bayer bonds? Here you find information for fixed income investors on our financial strategy, debt, credit rating, funding instruments, our bonds and credit relations contacts.

Bonds


Publication of Third Quarter 2017 results

Publication of Third Quarter 2017 results
  • Transcript (as soon as it becomes available)
     

Restatements 2016 / 2017 due to Covestro

Restatements 2016 / 2017 due to Covestro

With the deconsolidation of Covestro, this business will be reported as a discontinued operation in Bayer’s financial reporting for the third quarter of 2017.

For continuing operations, please find here adjusted Group figures for 2016 and Q1-Q2 2017 to exclude Covestro’s contributions.

In addition, all assets and liabilities allocated to Covestro will not feature in Bayer’s statement of financial position as of September 30. The remaining Covestro interest will be carried at the current market value, and, from October 1, 2017, will be accounted for using the equity method.

Restated key figures for 2016 and 2017Download (XLSX, 170 KB) collect


Q2 2017 All in One Package for Investors and Analysts

Q2 2017 All in One Package for Investors and Analysts

Service for Investors and Analysts:
Download all documents on our Second Quarter 2017 results in one ZIP file:

Download (ZIP, 2 MB) collect


Investor Conference Call: Bayer to Acquire Monsanto

Investor Conference Call: Bayer to Acquire Monsanto

Media conference call